Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

22 April 2026 : Review article  

Role of the STAT3 Signaling Pathway in Cell Proliferation and Inflammation in Psoriasis and Approaches for Targeted Therapies: A Review

Limin Li CE 1, Lu Chen B 1, Cai Zhang BEF 2, Wenchao Yao D 1, Zhengxiao Li G 3, Faming Tian G 1,2*

DOI: 10.12659/MSM.952449

Med Sci Monit 2026; 32:e952449

Figure 5 Macrophage-derived cytokines activate JAK2/STAT3 in keratinocytes, driving inflammation and hyperproliferationIn the pathological microenvironment of psoriasis, local macrophages in the skin can secrete pro-inflammatory factors such as interleukin-6 (IL-6) and IL-8 (CXCL8), which specifically act on keratinocytes and induce the activation of the intracellular JAK2/STAT3 signaling pathway. After this pathway is activated, it can widely upregulate the transcription and expression of downstream molecules: chemokines recruit neutrophils to accumulate at the inflammatory site, and interleukins further amplify the local inflammatory cascade reaction. Keratin 16 (K16) and Keratin 17 (K17) along with B-cell lymphoma 2 (Bcl-2) synergistically promote abnormal proliferation of keratinocytes (Bcl-2 maintains the proliferative phenotype through anti-apoptotic effects), and IL-6 can assist in promoting Th17 cell differentiation. These pathological processes work together to continuously intensify skin inflammation and promote the occurrence and progression of psoriasis. (Created with BioRender.com).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750